Investigating αv Integrin in Feline Injection-Site Sarcoma
Author Information
Author(s): Andrea Cappelleri, Eleonora Brambilla, Lavinia E. Chiti, Alessia Trapletti, Gaia B. M. Bianchi, Mauro Di Giancamillo, Valeria Grieco, Chiara Giudice
Primary Institution: Department of Veterinary Medicine and Animal Sciences, University of Milan
Hypothesis
Can αv integrin serve as a specific label for neoplastic cells in fixed tissues to assess the status of FISS margins?
Conclusion
The study found that while αv integrin is present in neoplastic cells, it cannot reliably distinguish between neoplastic and reactive cells in surgical margins.
Supporting Evidence
- All FISS cases showed positive staining for αv integrin.
- Spindle neoplastic cells in fibrosarcomas had mild-to-moderate cytoplasmic positivity.
- Pleomorphic sarcoma cells exhibited intense membranous positivity for αv integrin.
Takeaway
This study looked at a protein called αv integrin in cat tumors to see if it could help doctors tell if they got all the cancer out during surgery, but it didn't work as hoped.
Methodology
The study analyzed 10 feline excisional biopsies of FISS using immunohistochemistry to evaluate αv integrin expression.
Limitations
The antibody used did not effectively distinguish between neoplastic and reactive cells, limiting its utility in clinical settings.
Participant Demographics
The study included 10 cats, with 6 females and 3 males, aged between 10 and 21 years.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website